Suanfarma, S.A.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Suanfarma, S.A. - overview

Established

1993

Location

Madrid, -, Spain

Primary Industry

Pharmaceuticals

About

Based in Madrid, Spain, and founded in 1993 by Hector Ara, Suanfarma, S. A. is a life sciences company. In October 2015, ProA Capital acquired a majority stake in the company for EUR 25 million, supporting its growth both organically and through further acquisitions.


The firm has expanded and increased the industrial and development capacity of the business by acquiring companies in Spain, Portugal, Colombia, and Italy. Intermediate Capital Group later acquired a majority stake in Suanfarma, S. A. in June 2018 from ProA Capital, which retained a minority stake in the company.


In September 2021, ArchiMed acquired an 80% majority stake in the company from ProA Capital and Intermediate Capital Group for approximately EUR 500 million. As of December 2021, the firm is led by its CEO, Francisco Fernandez. Suanfarma, S. A.


develops, manufactures, and distributes active pharmaceutical ingredients, raw materials, generic medicines, and finished dosage forms used by the pharmaceutical, biotechnological, veterinary, nutritional, and cosmetic industries. In addition, the company serves as a Contract Development and Manufacturing Organization (CDMO), assisting clients with the commercialization of generic and unique APIs (Active Pharmaceutical Ingredient). The acquisition by Archimed will support Suanfarma, S. A’s product portfolio expansion and organic growth.


Current Investors

Primary Industry

Pharmaceuticals

Sub Industries

Health Foods & Nutritional Supplements, Biopharmaceuticals, Pharmaceutical Research & Development, Commodity Chemicals

Website

www.suanfarma.com

Verticals

Manufacturing

Company Stage

Mature

Total Amount Raised

Subscriber access only

Suanfarma, S.A. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
BuyoutCompletedSuanfarma, S.A.-
Secondary BuyoutCompletedSuanfarma, S.A.-
Secondary BuyoutCompletedSuanfarma, S.A.-
BuyoutCompletedSuanfarma, S.A.-

Displaying 1 - 4 of 4

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.